Statement Of Comprehensive Income [Abstract]

Pharming Group N.V. - Filing #5829944

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Statement of comprehensive income [abstract]
Profit (loss)	— USD	11,841,000 USD	— USD	— USD	11,841,000 USD	— USD	10,548,000 USD	10,548,000 USD	— USD	— USD
Other comprehensive income [abstract]
Components of other comprehensive income that will not be reclassified to profit or loss, net of tax [abstract]
Other comprehensive income, net of tax, gains (losses) from investments in equity instruments	—	79,000 USD	—	—	—	—	1,167,000 USD	—	—	—
Other comprehensive income that will not be reclassified to profit or loss, net of tax	—	79,000 USD	—	—	—	—	1,167,000 USD	—	—	—
Components of other comprehensive income that will be reclassified to profit or loss, net of tax [abstract]
Exchange differences on translation [abstract]
Other comprehensive income, net of tax, exchange differences on translation of foreign operations	—	11,980,000 USD	—	—	—	—	5,936,000 USD	—	—	—
Other comprehensive income that will be reclassified to profit or loss, net of tax	—	11,980,000 USD	—	—	—	—	5,936,000 USD	—	—	—
Other comprehensive income	— USD	11,901,000 USD	— USD	11,901,000 USD	— USD	— USD	7,103,000 USD	— USD	— USD	7,103,000 USD
Comprehensive income	— USD	23,742,000 USD	— USD	10,346,000 USD	13,396,000 USD	— USD	3,445,000 USD	10,548,000 USD	— USD	7,103,000 USD